Corona virus hits america again

Pharmaceutical companies invest heavily in R&D in order to discover and develop new drugs that can be brought to market. The R&D process can be very expensive and time-consuming, often taking many years and requiring significant investment in clinical trials, regulatory compliance, and marketing. As a result, the cost of developing a new drug can run into billions of dollars.

Axmed Secures $6M Grant Funding to Scale the Global Infrastructure for Access to Healthcare Products

Axmed, a health technology company headquartered in Switzerland with regional headquarters in Nairobi, Kenya, today announced it has been awarded $6 million in non-dilutive grant funding from the Gates Foundation to expand

Axmed and LifeNet International Announce Transformative Partnership to Expand Access to Essential Maternal and Newborn Health Products

Postpartum haemorrhage (PPH), is the leading cause of maternal death in Sub-Saharan Africa. Standard care in these settings often relies on visual estimates of blood loss, which frequently underestimates severity and delays critical interventions.

Axmed and Every Pregnancy Announce Transformative Partnership to Enhance Access to Affordable Essential Medicines for Mothers and Babies Affected by Conflict and Crisis

Rooted in a shared mission to ensure safe pregnancies and healthy babies, this new collaboration will provide Every Pregnancy partners access to affordable and quality medicines through Axmed’s pioneering B2B marketplace.

$5 million Gates Foundation Grant Powers $10 million MNCH Procurement via Axmed Platform

The Gates Foundation has awarded a $5 million grant to Axmed, a healthcare technology company transforming how essential medicines are procured across Growth Markets.

A Wake-up Call? Radical Action for Smarter Medicine Access

For decades, global health procurement – on which over six billion people depend – has mostly relied on one system: centralized multilateral institutions pooling donor funding to purchase and distribute medicines across low- and middle-income countries.

Emcure and Axmed Unite to Combat Maternal and Newborn Mortality: A Bold Step Toward Equitable Healthcare Access

Emcure and Axmed unite to tackle maternal and newborn mortality, promoting equitable healthcare access. Discover how this collaboration is transforming global health outcomes.